Latest News & Features
Americas
The US Court of Appeals for the Federal Circuit has said it won’t review a writ filed by Illumina and its subsidiary Verinata Health in a patent dispute with Ariosa Diagnostics. 10 March 2017
Americas
The Patent Trial and Appeal Board upheld Acorda Therapeutics’ patents covering the drug Ampyra in a case against Kyle Bass’s Coalition for Affordable Drugs in a decision handed down yesterday. 10 March 2017
Americas
A jury at the US District Court for the District of Delaware has decided that medical technologies company C R Bard has not infringed a patent owned by W L Gore Associates, a company specialising in products derived from fluoropolymers. 9 March 2017
Americas
US-based Vertex Pharmaceuticals has agreed to acquire a potential treatment for cystic fibrosis from Concert Pharmaceuticals, also in the US, for $160 million. 9 March 2017
Asia
Bayer has been defeated in a patent battle against India-based drugs companies Alembic Pharmaceuticals and Natco Pharma today. 8 March 2017
Americas
US-based biopharmaceutical company Arena Pharmaceuticals and Eisai, a drugs company based in Japan, have filed a complaint against Teva for patent infringement over a weight-loss generic drug. 8 March 2017
Americas
Two biotech associations have filed a petition asking the US Court of Appeals for the Federal Circuit to clarify rules on whether arguments can be brought at a district court if they have been brought at the US Patent and Trademark Office. 7 March 2017
Americas
The Patent Trial and Appeal Board has rejected Celltrion’s challenge against a Genentech patent centring on a method of treating rheumatoid arthritis, stating that the challenged patent did not show any reasonable likelihood of being invalid. 7 March 2017
Americas
Law firm Cooley has hired Ryan Sansom as a partner to enhance its life sciences practice in Boston. 6 March 2017
Biotechnology
The English High Court has ruled in favour of Fujifilm Kyowa Kirin Biologics in a case against AbbVie, granting Fujifilm an Arrow declaration allowing it to market a biosimilar of AbbVie’s Humira (adalimumab), a medication used to treat arthritis. 6 March 2017